<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-07-26" modified="2020-10-07" version="181">
<accession>Q9Y6X9</accession>
<accession>B2RNB1</accession>
<accession>Q9UF28</accession>
<accession>Q9Y6V2</accession>
<name>MORC2_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="30">ATPase MORC2</fullName>
<ecNumber evidence="19 25 27">3.6.1.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="30">MORC family CW-type zinc finger protein 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Zinc finger CW-type coiled-coil domain protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="31">MORC2</name>
<name type="synonym">KIAA0852</name>
<name type="synonym">ZCWCC1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="DNA Res." volume="5" first="355" last="364">
<title>Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Suyama M."/>
<person name="Kikuno R."/>
<person name="Hirosawa M."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10048485"/>
<dbReference type="DOI" id="10.1093/dnares/5.6.355"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R84.1" last="R84.11">
<title>A genome annotation-driven approach to cloning the human ORFeome.</title>
<authorList>
<person name="Collins J.E."/>
<person name="Wright C.L."/>
<person name="Edwards C.A."/>
<person name="Davis M.P."/>
<person name="Grinham J.A."/>
<person name="Cole C.G."/>
<person name="Goward M.E."/>
<person name="Aguado B."/>
<person name="Mallya M."/>
<person name="Mokrab Y."/>
<person name="Huckle E.J."/>
<person name="Beare D.M."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15461802"/>
<dbReference type="DOI" id="10.1186/gb-2004-5-10-r84"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Nature" volume="402" first="489" last="495">
<title>The DNA sequence of human chromosome 22.</title>
<authorList>
<person name="Dunham I."/>
<person name="Hunt A.R."/>
<person name="Collins J.E."/>
<person name="Bruskiewich R."/>
<person name="Beare D.M."/>
<person name="Clamp M."/>
<person name="Smink L.J."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Buck D."/>
<person name="Burgess J."/>
<person name="Burrill W.D."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chen Y."/>
<person name="Clark G."/>
<person name="Clegg S.M."/>
<person name="Cobley V.E."/>
<person name="Cole C.G."/>
<person name="Collier R.E."/>
<person name="Connor R."/>
<person name="Conroy D."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Cox A.V."/>
<person name="Davis J."/>
<person name="Dawson E."/>
<person name="Dhami P.D."/>
<person name="Dockree C."/>
<person name="Dodsworth S.J."/>
<person name="Durbin R.M."/>
<person name="Ellington A.G."/>
<person name="Evans K.L."/>
<person name="Fey J.M."/>
<person name="Fleming K."/>
<person name="French L."/>
<person name="Garner A.A."/>
<person name="Gilbert J.G.R."/>
<person name="Goward M.E."/>
<person name="Grafham D.V."/>
<person name="Griffiths M.N.D."/>
<person name="Hall C."/>
<person name="Hall R.E."/>
<person name="Hall-Tamlyn G."/>
<person name="Heathcott R.W."/>
<person name="Ho S."/>
<person name="Holmes S."/>
<person name="Hunt S.E."/>
<person name="Jones M.C."/>
<person name="Kershaw J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.F."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Martyn I.D."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L.H."/>
<person name="Mccann O.T."/>
<person name="Mcclay J."/>
<person name="Mclaren S."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mortimore B.J."/>
<person name="Odell C.N."/>
<person name="Pavitt R."/>
<person name="Pearce A.V."/>
<person name="Pearson D."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S.H."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Ramsey Y."/>
<person name="Rogers L."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Skuce C.D."/>
<person name="Smalley S."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Spragon L."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whiteley M.N."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Williamson H."/>
<person name="Wilmer T.E."/>
<person name="Wilming L."/>
<person name="Wright C.L."/>
<person name="Hubbard T."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Shimizu N."/>
<person name="Minoshima S."/>
<person name="Kawasaki K."/>
<person name="Sasaki T."/>
<person name="Asakawa S."/>
<person name="Kudoh J."/>
<person name="Shintani A."/>
<person name="Shibuya K."/>
<person name="Yoshizaki Y."/>
<person name="Aoki N."/>
<person name="Mitsuyama S."/>
<person name="Roe B.A."/>
<person name="Chen F."/>
<person name="Chu L."/>
<person name="Crabtree J."/>
<person name="Deschamps S."/>
<person name="Do A."/>
<person name="Do T."/>
<person name="Dorman A."/>
<person name="Fang F."/>
<person name="Fu Y."/>
<person name="Hu P."/>
<person name="Hua A."/>
<person name="Kenton S."/>
<person name="Lai H."/>
<person name="Lao H.I."/>
<person name="Lewis J."/>
<person name="Lewis S."/>
<person name="Lin S.-P."/>
<person name="Loh P."/>
<person name="Malaj E."/>
<person name="Nguyen T."/>
<person name="Pan H."/>
<person name="Phan S."/>
<person name="Qi S."/>
<person name="Qian Y."/>
<person name="Ray L."/>
<person name="Ren Q."/>
<person name="Shaull S."/>
<person name="Sloan D."/>
<person name="Song L."/>
<person name="Wang Q."/>
<person name="Wang Y."/>
<person name="Wang Z."/>
<person name="White J."/>
<person name="Willingham D."/>
<person name="Wu H."/>
<person name="Yao Z."/>
<person name="Zhan M."/>
<person name="Zhang G."/>
<person name="Chissoe S."/>
<person name="Murray J."/>
<person name="Miller N."/>
<person name="Minx P."/>
<person name="Fulton R."/>
<person name="Johnson D."/>
<person name="Bemis G."/>
<person name="Bentley D."/>
<person name="Bradshaw H."/>
<person name="Bourne S."/>
<person name="Cordes M."/>
<person name="Du Z."/>
<person name="Fulton L."/>
<person name="Goela D."/>
<person name="Graves T."/>
<person name="Hawkins J."/>
<person name="Hinds K."/>
<person name="Kemp K."/>
<person name="Latreille P."/>
<person name="Layman D."/>
<person name="Ozersky P."/>
<person name="Rohlfing T."/>
<person name="Scheet P."/>
<person name="Walker C."/>
<person name="Wamsley A."/>
<person name="Wohldmann P."/>
<person name="Pepin K."/>
<person name="Nelson J."/>
<person name="Korf I."/>
<person name="Bedell J.A."/>
<person name="Hillier L.W."/>
<person name="Mardis E."/>
<person name="Waterston R."/>
<person name="Wilson R."/>
<person name="Emanuel B.S."/>
<person name="Shaikh T."/>
<person name="Kurahashi H."/>
<person name="Saitta S."/>
<person name="Budarf M.L."/>
<person name="McDermid H.E."/>
<person name="Johnson A."/>
<person name="Wong A.C.C."/>
<person name="Morrow B.E."/>
<person name="Edelmann L."/>
<person name="Kim U.J."/>
<person name="Shizuya H."/>
<person name="Simon M.I."/>
<person name="Dumanski J.P."/>
<person name="Peyrard M."/>
<person name="Kedra D."/>
<person name="Seroussi E."/>
<person name="Fransson I."/>
<person name="Tapia I."/>
<person name="Bruder C.E."/>
<person name="O'Brien K.P."/>
<person name="Wilkinson P."/>
<person name="Bodenteich A."/>
<person name="Hartman K."/>
<person name="Hu X."/>
<person name="Khan A.S."/>
<person name="Lane L."/>
<person name="Tilahun Y."/>
<person name="Wright H."/>
</authorList>
<dbReference type="PubMed" id="10591208"/>
<dbReference type="DOI" id="10.1038/990031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Cerebellum</tissue>
<tissue>Neuroblastoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 712-1032</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-615</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-696; SER-705; SER-725; SER-730; THR-733; SER-777 AND SER-779</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-739 AND SER-743</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2010" name="Anat. Rec." volume="293" first="1002" last="1009">
<title>Identification and expression analysis of a novel CW-type zinc finger protein MORC2 in cancer cells.</title>
<authorList>
<person name="Wang G.L."/>
<person name="Wang C.Y."/>
<person name="Cai X.Z."/>
<person name="Chen W."/>
<person name="Wang X.H."/>
<person name="Li F."/>
</authorList>
<dbReference type="PubMed" id="20225202"/>
<dbReference type="DOI" id="10.1002/ar.21119"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="2813" last="2824">
<title>Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX.</title>
<authorList>
<person name="Shao Y."/>
<person name="Li Y."/>
<person name="Zhang J."/>
<person name="Liu D."/>
<person name="Liu F."/>
<person name="Zhao Y."/>
<person name="Shen T."/>
<person name="Li F."/>
</authorList>
<dbReference type="PubMed" id="20110259"/>
<dbReference type="DOI" id="10.1093/nar/gkq006"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HDAC4</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-615; SER-743; SER-777 AND SER-779</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-615; SER-739; SER-743; SER-777 AND SER-779</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="Cell Rep." volume="2" first="1657" last="1669">
<title>MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response.</title>
<authorList>
<person name="Li D.Q."/>
<person name="Nair S.S."/>
<person name="Ohshiro K."/>
<person name="Kumar A."/>
<person name="Nair V.S."/>
<person name="Pakala S.B."/>
<person name="Reddy S.D."/>
<person name="Gajula R.P."/>
<person name="Eswaran J."/>
<person name="Aravind L."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="23260667"/>
<dbReference type="DOI" id="10.1016/j.celrep.2012.11.018"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-739</scope>
<scope>MUTAGENESIS OF ASP-68; ASP-69; SER-725; SER-730; SER-739 AND SER-773</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-582; SER-602; SER-615; SER-696; SER-705; SER-725; SER-730; THR-733; SER-739; SER-743; SER-777 AND SER-779</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="Biochim. Biophys. Acta" volume="1843" first="316" last="326">
<title>Cytosolic functions of MORC2 in lipogenesis and adipogenesis.</title>
<authorList>
<person name="Sanchez-Solana B."/>
<person name="Li D.Q."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="24286864"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2013.11.012"/>
</citation>
<scope>FUNCTION IN LIPID HOMEOSTASIS</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ACLY</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-615</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-767</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-652; LYS-704; LYS-716; LYS-767; LYS-819 AND LYS-932</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2018" name="Nature" volume="553" first="228" last="232">
<title>Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators.</title>
<authorList>
<person name="Liu N."/>
<person name="Lee C.H."/>
<person name="Swigut T."/>
<person name="Grow E."/>
<person name="Gu B."/>
<person name="Bassik M.C."/>
<person name="Wysocka J."/>
</authorList>
<dbReference type="PubMed" id="29211708"/>
<dbReference type="DOI" id="10.1038/nature25179"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2016" name="Ann. Neurol." volume="79" first="419" last="427">
<title>MORC2 mutations cause axonal Charcot-Marie-Tooth disease with pyramidal signs.</title>
<authorList>
<person name="Albulym O.M."/>
<person name="Kennerson M.L."/>
<person name="Harms M.B."/>
<person name="Drew A.P."/>
<person name="Siddell A.H."/>
<person name="Auer-Grumbach M."/>
<person name="Pestronk A."/>
<person name="Connolly A."/>
<person name="Baloh R.H."/>
<person name="Zuchner S."/>
<person name="Reddel S.W."/>
<person name="Nicholson G.A."/>
</authorList>
<dbReference type="PubMed" id="26659848"/>
<dbReference type="DOI" id="10.1002/ana.24575"/>
</citation>
<scope>VARIANTS CMT2Z GLU-96; GLY-236; TRP-252 AND ARG-444</scope>
<scope>VARIANTS CYS-248; HIS-283; HIS-466; CYS-585 AND GLY-757</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2016" name="Brain" volume="139" first="62" last="72">
<title>Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.</title>
<authorList>
<person name="Sevilla T."/>
<person name="Lupo V."/>
<person name="Martinez-Rubio D."/>
<person name="Sancho P."/>
<person name="Sivera R."/>
<person name="Chumillas M.J."/>
<person name="Garcia-Romero M."/>
<person name="Pascual-Pascual S.I."/>
<person name="Muelas N."/>
<person name="Dopazo J."/>
<person name="Vilchez J.J."/>
<person name="Palau F."/>
<person name="Espinos C."/>
</authorList>
<dbReference type="PubMed" id="26497905"/>
<dbReference type="DOI" id="10.1093/brain/awv311"/>
</citation>
<scope>VARIANTS CMT2Z LEU-87 AND TRP-252</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2016" name="Brain" volume="139" first="E70" last="E70">
<title>MORC2 mutation causes severe spinal muscular atrophy-phenotype, cerebellar atrophy, and diaphragmatic paralysis.</title>
<authorList>
<person name="Schottmann G."/>
<person name="Wagner C."/>
<person name="Seifert F."/>
<person name="Stenzel W."/>
<person name="Schuelke M."/>
</authorList>
<dbReference type="PubMed" id="27794525"/>
<dbReference type="DOI" id="10.1093/brain/aww252"/>
</citation>
<scope>VARIANT ARG-424</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="Brain" volume="140" first="E34" last="E34">
<title>De novo p.T362R mutation in MORC2 causes early onset cerebellar ataxia, axonal polyneuropathy and nocturnal hypoventilation.</title>
<authorList>
<person name="Zanni G."/>
<person name="Nardella M."/>
<person name="Barresi S."/>
<person name="Bellacchio E."/>
<person name="Niceta M."/>
<person name="Ciolfi A."/>
<person name="Pro S."/>
<person name="D'Arrigo S."/>
<person name="Tartaglia M."/>
<person name="Bertini E."/>
</authorList>
<dbReference type="PubMed" id="28402445"/>
<dbReference type="DOI" id="10.1093/brain/awx083"/>
</citation>
<scope>VARIANT ARG-424</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2017" name="Nat. Genet." volume="49" first="1035" last="1044">
<title>Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2.</title>
<authorList>
<person name="Tchasovnikarova I.A."/>
<person name="Timms R.T."/>
<person name="Douse C.H."/>
<person name="Roberts R.C."/>
<person name="Dougan G."/>
<person name="Kingston R.E."/>
<person name="Modis Y."/>
<person name="Lehner P.J."/>
</authorList>
<dbReference type="PubMed" id="28581500"/>
<dbReference type="DOI" id="10.1038/ng.3878"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT CMT2Z TRP-252</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TASOR AND MPHOSPH8</scope>
<scope>MUTAGENESIS OF ASN-39 AND ASP-68</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>DSDNA-BINDING</scope>
</reference>
<reference key="30" evidence="1 2 3">
<citation type="journal article" date="2018" name="Nat. Commun." volume="9" first="651" last="651">
<title>Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms.</title>
<authorList>
<person name="Douse C.H."/>
<person name="Bloor S."/>
<person name="Liu Y."/>
<person name="Shamin M."/>
<person name="Tchasovnikarova I.A."/>
<person name="Timms R.T."/>
<person name="Lehner P.J."/>
<person name="Modis Y."/>
</authorList>
<dbReference type="PubMed" id="29440755"/>
<dbReference type="DOI" id="10.1038/s41467-018-03045-x"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS) OF 1-603 OF WILD-TYPE</scope>
<scope>X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS) OF 1-603 OF</scope>
<scope>X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS) OF 1-603 OF VARIANT CMT2Z LEU-87</scope>
<scope>X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS) OF 1-603 OF VARIANT ARG-424 IN COMPLEX WITH ATP; MAGNESIUM AND ZINC</scope>
<scope>CHARACTERIZATION OF VARIANTS CMT2Z LEU-87 AND TRP-252</scope>
<scope>CHARACTERIZATION OF VARIANT ARG-424</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF TYR-18; ASN-39; ARG-266; ARG-319; ARG-326; ARG-329; ARG-333; ARG-344; ARG-351 AND ARG-358</scope>
</reference>
<comment type="function">
<text evidence="17 18 19 20 25 26 27">Essential for epigenetic silencing by the HUSH (human silencing hub) complex. Recruited by HUSH to target site in heterochromatin, the ATPase activity and homodimerization are critical for HUSH-mediated silencing (PubMed:28581500, PubMed:29440755). Represses germ cell-related genes and L1 retrotransposons in collaboration with SETDB1 and the HUSH complex, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression (PubMed:29211708). During DNA damage response, regulates chromatin remodeling through ATP hydrolysis. Upon DNA damage, is phosphorylated by PAK1, both colocalize to chromatin and induce H2AX expression. ATPase activity is required and dependent of phosphorylation by PAK1 and presence of DNA (PubMed:23260667). Recruits histone deacetylases, such as HDAC4, to promoter regions, causing local histone H3 deacetylation and transcriptional repression of genes such as CA9 (PubMed:20225202, PubMed:20110259). Exhibits a cytosolic function in lipogenesis, adipogenic differentiation, and lipid homeostasis by increasing the activity of ACLY, possibly preventing its dephosphorylation (PubMed:24286864).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="19 25 27">
<text>ATP + H2O = ADP + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:13065"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="19">
<dbReference type="Rhea" id="RHEA:13066"/>
</physiologicalReaction>
</comment>
<comment type="activity regulation">
<text evidence="19">ATPase activity is dependent of phosphorylation by PAK1 and presence of DNA.</text>
</comment>
<comment type="subunit">
<text evidence="17 20 25 27">Homodimerizes upon ATP-binding and dissociate upon ATP hydrolysis; homodimerization is required for gene silencing (PubMed:29440755). Interacts with HDAC4 (PubMed:20110259). Interacts with ACLY (PubMed:24286864). Interacts with TASOR and MPHOSPH8; the interactions associate MORC2 with the HUSH complex which recruits MORC2 to heterochromatic loci (PubMed:28581500).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="18 19 25">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="18 20">Cytoplasm</location>
<location evidence="18 20">Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 25">Chromosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Nucleus matrix</location>
</subcellularLocation>
<text evidence="18 19">Mainly located in the nucleus (PubMed:20225202). Upon phosphorylation at Ser-739, recruited to damaged chromatin (PubMed:23260667).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y6X9-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y6X9-2</id>
<name>2</name>
<sequence type="described" ref="VSP_041759"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Highly expressed in smooth muscle, pancreas and testis.</text>
</comment>
<comment type="PTM">
<text evidence="19">Phosphorylated by PAK1 at Ser-739 upon DNA damage. Phosphorylation is required for ATPase activity and recruitment to damaged chromatin.</text>
</comment>
<comment type="disease" evidence="21 22 25 27">
<disease id="DI-04590">
<name>Charcot-Marie-Tooth disease 2Z</name>
<acronym>CMT2Z</acronym>
<description>An autosomal dominant, axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.</description>
<dbReference type="MIM" id="616688"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="30">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAC12954" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="30">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="BAA74875" version="2"/>
</conflict>
<text>Intron retention.</text>
</comment>
<dbReference type="EC" id="3.6.1.-" evidence="19 25 27"/>
<dbReference type="EMBL" id="AB020659">
<property type="protein sequence ID" value="BAA74875.2"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR456469">
<property type="protein sequence ID" value="CAG30355.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004542">
<property type="protein sequence ID" value="AAC12954.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL133637">
<property type="protein sequence ID" value="CAB63760.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471095">
<property type="protein sequence ID" value="EAW59921.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC019257">
<property type="protein sequence ID" value="AAH19257.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136782">
<property type="protein sequence ID" value="AAI36783.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33636.1">
<molecule id="Q9Y6X9-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS77668.1">
<molecule id="Q9Y6X9-1"/>
</dbReference>
<dbReference type="PIR" id="T02436">
<property type="entry name" value="T02436"/>
</dbReference>
<dbReference type="PIR" id="T43455">
<property type="entry name" value="T43455"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001290185.1">
<molecule id="Q9Y6X9-1"/>
<property type="nucleotide sequence ID" value="NM_001303256.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001290186.1">
<property type="nucleotide sequence ID" value="NM_001303257.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055756.1">
<molecule id="Q9Y6X9-2"/>
<property type="nucleotide sequence ID" value="NM_014941.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016884157.1">
<property type="nucleotide sequence ID" value="XM_017028668.1"/>
</dbReference>
<dbReference type="PDB" id="5OF9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.81"/>
<property type="chains" value="A/B=1-603"/>
</dbReference>
<dbReference type="PDB" id="5OFA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.57"/>
<property type="chains" value="A/B=1-603"/>
</dbReference>
<dbReference type="PDB" id="5OFB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A/B=1-603"/>
</dbReference>
<dbReference type="PDBsum" id="5OF9"/>
<dbReference type="PDBsum" id="5OFA"/>
<dbReference type="PDBsum" id="5OFB"/>
<dbReference type="SMR" id="Q9Y6X9"/>
<dbReference type="BioGRID" id="116547">
<property type="interactions" value="22"/>
</dbReference>
<dbReference type="IntAct" id="Q9Y6X9">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="MINT" id="Q9Y6X9"/>
<dbReference type="STRING" id="9606.ENSP00000215862"/>
<dbReference type="iPTMnet" id="Q9Y6X9"/>
<dbReference type="PhosphoSitePlus" id="Q9Y6X9"/>
<dbReference type="BioMuta" id="MORC2"/>
<dbReference type="DMDM" id="114152840"/>
<dbReference type="EPD" id="Q9Y6X9"/>
<dbReference type="jPOST" id="Q9Y6X9"/>
<dbReference type="MassIVE" id="Q9Y6X9"/>
<dbReference type="PaxDb" id="Q9Y6X9"/>
<dbReference type="PeptideAtlas" id="Q9Y6X9"/>
<dbReference type="PRIDE" id="Q9Y6X9"/>
<dbReference type="ProteomicsDB" id="86822">
<molecule id="Q9Y6X9-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86823">
<molecule id="Q9Y6X9-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="235">
<property type="antibodies" value="130 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="22880"/>
<dbReference type="Ensembl" id="ENST00000215862">
<molecule id="Q9Y6X9-2"/>
<property type="protein sequence ID" value="ENSP00000215862"/>
<property type="gene ID" value="ENSG00000133422"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000397641">
<molecule id="Q9Y6X9-1"/>
<property type="protein sequence ID" value="ENSP00000380763"/>
<property type="gene ID" value="ENSG00000133422"/>
</dbReference>
<dbReference type="GeneID" id="22880"/>
<dbReference type="KEGG" id="hsa:22880"/>
<dbReference type="UCSC" id="uc003aje.2">
<molecule id="Q9Y6X9-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="22880"/>
<dbReference type="DisGeNET" id="22880"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000133422.12"/>
<dbReference type="GeneCards" id="MORC2"/>
<dbReference type="GeneReviews" id="MORC2"/>
<dbReference type="HGNC" id="HGNC:23573">
<property type="gene designation" value="MORC2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000133422">
<property type="expression patterns" value="Tissue enhanced (testis)"/>
</dbReference>
<dbReference type="MalaCards" id="MORC2"/>
<dbReference type="MIM" id="616661">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616688">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y6X9"/>
<dbReference type="OpenTargets" id="ENSG00000133422"/>
<dbReference type="Orphanet" id="466768">
<property type="disease" value="Autosomal dominant Charcot-Marie-Tooth disease type 2Z"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134986990"/>
<dbReference type="eggNOG" id="KOG1845">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153998"/>
<dbReference type="HOGENOM" id="CLU_011516_0_0_1"/>
<dbReference type="InParanoid" id="Q9Y6X9"/>
<dbReference type="KO" id="K24135"/>
<dbReference type="OMA" id="SQDRCDA"/>
<dbReference type="OrthoDB" id="193855at2759"/>
<dbReference type="PhylomeDB" id="Q9Y6X9"/>
<dbReference type="TreeFam" id="TF329118"/>
<dbReference type="PathwayCommons" id="Q9Y6X9"/>
<dbReference type="Reactome" id="R-HSA-75105">
<property type="pathway name" value="Fatty acyl-CoA biosynthesis"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="22880">
<property type="hits" value="21 hits in 871 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MORC2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="MORC2"/>
<dbReference type="GenomeRNAi" id="22880"/>
<dbReference type="Pharos" id="Q9Y6X9">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9Y6X9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 22"/>
</dbReference>
<dbReference type="RNAct" id="Q9Y6X9">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000133422">
<property type="expression patterns" value="Expressed in amniotic fluid and 242 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9Y6X9">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y6X9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000792">
<property type="term" value="C:heterochromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016887">
<property type="term" value="F:ATPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006338">
<property type="term" value="P:chromatin remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006631">
<property type="term" value="P:fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045814">
<property type="term" value="P:negative regulation of gene expression, epigenetic"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045869">
<property type="term" value="P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090309">
<property type="term" value="P:positive regulation of DNA methylation-dependent heterochromatin assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036890">
<property type="entry name" value="HATPase_C_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR041006">
<property type="entry name" value="Morc_S5"/>
</dbReference>
<dbReference type="InterPro" id="IPR011124">
<property type="entry name" value="Znf_CW"/>
</dbReference>
<dbReference type="Pfam" id="PF17942">
<property type="entry name" value="Morc6_S5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07496">
<property type="entry name" value="zf-CW"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55874">
<property type="entry name" value="SSF55874"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51050">
<property type="entry name" value="ZF_CW"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0144">Charcot-Marie-Tooth disease</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0276">Fatty acid metabolism</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0622">Neuropathy</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="9 10">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="ATPase MORC2" id="PRO_0000096537">
<location>
<begin position="2"/>
<end position="1032"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="27">
<location>
<begin position="87"/>
<end position="89"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="27">
<location>
<begin position="99"/>
<end position="105"/>
</location>
</feature>
<feature type="zinc finger region" description="CW-type" evidence="16 27">
<location>
<begin position="490"/>
<end position="544"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="15">
<location>
<begin position="282"/>
<end position="362"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="15">
<location>
<begin position="547"/>
<end position="584"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="15">
<location>
<begin position="741"/>
<end position="761"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="15">
<location>
<begin position="966"/>
<end position="1016"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium" evidence="27">
<location>
<position position="39"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="27">
<location>
<position position="39"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="27">
<location>
<position position="427"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="9 10">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="582"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="602"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 7 8 11 12">
<location>
<position position="615"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 11">
<location>
<position position="696"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 11">
<location>
<position position="705"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 11">
<location>
<position position="725"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 11">
<location>
<position position="730"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 11">
<location>
<position position="733"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PAK1" evidence="6 8 11 19">
<location>
<position position="739"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 8 11">
<location>
<position position="743"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7 8 11">
<location>
<position position="777"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7 8 11">
<location>
<position position="779"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="652"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="704"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="716"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13 14">
<location>
<position position="767"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="819"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="932"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_041759" evidence="28 29">
<location>
<begin position="1"/>
<end position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2Z; decreased ATPase activity; ATP-independent homodimerization; slightly increases HUSH-dependent gene silencing; dbSNP:rs864309504." id="VAR_076454" evidence="21">
<original>S</original>
<variation>L</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2Z; unknown pathological significance; dbSNP:rs749060708." id="VAR_076455" evidence="22">
<original>Q</original>
<variation>E</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2Z; dbSNP:rs886037934." id="VAR_076456" evidence="22">
<original>E</original>
<variation>G</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1355363942." id="VAR_076457" evidence="22">
<original>Y</original>
<variation>C</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2Z; slightly decreased ATPase activity; increased HUSH-dependent gene silencing in neuronal cells; dbSNP:rs864309503." id="VAR_076458" evidence="21 22 25 27">
<original>R</original>
<variation>W</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1482880426." id="VAR_076459" evidence="22">
<original>R</original>
<variation>H</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in a child with spinal atrophy-phenotype, cerebellar atrophy and diaphragmatic paralysis as well a second child with early onset cerebbellar ataxia, axonal polyneuropathy and nocturanl hypoventilation; increased ATPase activity; increased rate of dimer assembly and disassembly; decreased HUSH-dependent gene silencing." id="VAR_081260" evidence="23 24 27">
<original>T</original>
<variation>R</variation>
<location>
<position position="424"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2Z; unknown pathological significance." id="VAR_076460" evidence="22">
<original>G</original>
<variation>R</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_076461" evidence="22">
<original>D</original>
<variation>H</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs548292999." id="VAR_076462" evidence="22">
<original>R</original>
<variation>C</variation>
<location>
<position position="585"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs774444542." id="VAR_076463" evidence="22">
<original>E</original>
<variation>G</variation>
<location>
<position position="757"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes homodimerization. No effect on ATPase activity. Loss of HUSH-dependent gene silencing." evidence="27">
<original>Y</original>
<variation>A</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ATP-binding and ATPase activity. Does not homodimerizes. Seems to abolish chromatin compaction." evidence="25 27">
<original>N</original>
<variation>A</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ATP-binding and ATPase activity. Loss of binding to ATP and ATPase activity; when associated with A-69. Unables chromatin remodeling." evidence="19 25">
<original>D</original>
<variation>A</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on binding to ATP and ATPase activity; when associated with A-68." evidence="19">
<original>D</original>
<variation>A</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases HUSH-dependent gene silencing." evidence="27">
<original>R</original>
<variation>A</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on HUSH-dependent gene silencing." evidence="27">
<original>R</original>
<variation>E</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity; when associated with E-329 and E-333." evidence="27">
<original>R</original>
<variation>E</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity; when associated with E-326 and E-333." evidence="27">
<original>R</original>
<variation>E</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity; when associated with E-326 and E-329." evidence="27">
<original>R</original>
<variation>E</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on HUSH-dependent gene silencing." evidence="27">
<original>R</original>
<variation>E</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on HUSH-dependent gene silencing." evidence="27">
<original>R</original>
<variation>E</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on HUSH-dependent gene silencing." evidence="27">
<original>R</original>
<variation>E</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation by PAK1." evidence="19">
<original>S</original>
<variation>A</variation>
<location>
<position position="725"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation by PAK1." evidence="19">
<original>S</original>
<variation>A</variation>
<location>
<position position="730"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by PAK1. Not recruited on damaged chromatin. Loss of ATPase activity. Unables chromatin remodeling. Upon irradiation, increases levels of damaged DNA." evidence="19">
<original>S</original>
<variation>A</variation>
<location>
<position position="739"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation by PAK1." evidence="19">
<original>S</original>
<variation>A</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="17"/>
<end position="23"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="29"/>
<end position="42"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="46"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="61"/>
<end position="68"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="75"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="83"/>
<end position="85"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="103"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="112"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="132"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="149"/>
<end position="151"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="152"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="162"/>
<end position="175"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="181"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="193"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="212"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="217"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="224"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="235"/>
<end position="237"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="240"/>
<end position="246"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="247"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="253"/>
<end position="257"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="267"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="270"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="282"/>
<end position="320"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="331"/>
<end position="361"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="365"/>
<end position="372"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="381"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="389"/>
<end position="395"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="398"/>
<end position="401"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="402"/>
<end position="405"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="406"/>
<end position="409"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="410"/>
<end position="416"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="418"/>
<end position="420"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="427"/>
<end position="431"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="433"/>
<end position="454"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="456"/>
<end position="459"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="461"/>
<end position="467"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="472"/>
<end position="474"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="483"/>
<end position="490"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="495"/>
<end position="498"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="500"/>
<end position="502"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="505"/>
<end position="510"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="512"/>
<end position="514"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="525"/>
<end position="527"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="531"/>
<end position="533"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5OF9"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5OFA"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5OFB"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255"/>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00454"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20110259"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20225202"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23260667"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24286864"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26497905"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26659848"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27794525"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28402445"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28581500"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29211708"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29440755"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15461802"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<evidence key="31" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:23573"/>
</source>
</evidence>
<sequence length="1032" mass="117823" checksum="7BEFA46E4150ABF5" modified="2006-09-05" version="2">MAFTNYSSLNRAQLTFEYLHTNSTTHEFLFGALAELVDNARDADATRIDIYAERREDLRGGFMLCFLDDGAGMDPSDAASVIQFGKSAKRTPESTQIGQYGNGLKSGSMRIGKDFILFTKKEDTMTCLFLSRTFHEEEGIDEVIVPLPTWNARTREPVTDNVEKFAIETELIYKYSPFRTEEEVMTQFMKIPGDSGTLVIIFNLKLMDNGEPELDIISNPRDIQMAETSPEGTKPERRSFRAYAAVLYIDPRMRIFIHGHKVQTKRLSCCLYKPRMYKYTSSRFKTRAEQEVKKAEHVARIAEEKAREAESKARTLEVRLGGDLTRDSRVMLRQVQNRAITLRREADVKKRIKEAKQRALKEPKELNFVFGVNIEHRDLDGMFIYNCSRLIKMYEKVGPQLEGGMACGGVVGVVDVPYLVLEPTHNKQDFADAKEYRHLLRAMGEHLAQYWKDIAIAQRGIIKFWDEFGYLSANWNQPPSSELRYKRRRAMEIPTTIQCDLCLKWRTLPFQLSSVEKDYPDTWVCSMNPDPEQDRCEASEQKQKVPLGTFRKDMKTQEEKQKQLTEKIRQQQEKLEALQKTTPIRSQADLKKLPLEVTTRPSTEEPVRRPQRPRSPPLPAVIRNAPSRPPSLPTPRPASQPRKAPVISSTPKLPALAAREEASTSRLLQPPEAPRKPANTLVKTASRPAPLVQQLSPSLLPNSKSPREVPSPKVIKTPVVKKTESPIKLSPATPSRKRSVAVSDEEEVEEEAERRKERCKRGRFVVKEEKKDSNELSDSAGEEDSADLKRAQKDKGLHVEVRVNREWYTGRVTAVEVGKHVVRWKVKFDYVPTDTTPRDRWVEKGSEDVRLMKPPSPEHQSLDTQQEGGEEEVGPVAQQAIAVAEPSTSECLRIEPDTTALSTNHETIDLLVQILRNCLRYFLPPSFPISKKQLSAMNSDELISFPLKEYFKQYEVGLQNLCNSYQSRADSRAKASEESLRTSERKLRETEEKLQKLRTNIVALLQKVQEDIDINTDDELDAYIEDLITKGD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

